Index Entries

1089 Results
TitleIS Publication Date
Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center StudyMarch 4, 2023
Emergency Department Visits for Suspected Suicide Attempts Among Persons Aged 12–25 Years Before and During the COVID-19 Pandemic — United States, January 2019–May 2021June 18, 2021
Emergency Use Authorization for Vaccines to Prevent COVID-19 - Guidance for IndustryOctober 2020
Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 PatientsMay 28, 2020
Epidemic outcomes following government responses to COVID-19: Insights from nearly 100,000 modelsJune 5, 2024
Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty VaccinationNovember 28, 2021
Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, CanadaJune 24, 2022
Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart reviewMarch 21, 2022
Estimated COVID-19 Burden
Estimating the burden of SARS-CoV-2 in FranceJuly 10, 2020
Estimating the infection fatality ratio in EnglandAugust 21, 2020
Estimating the number of COVID vaccine deaths in America
Ethics of COVID-19-related school closuresAugust 7, 2020
EudraVigilance
Evaluating Data Integrity and Reporting Challenges in Public Health: Lessons from COVID-19 Data Collection in Washington StateOctober 15, 2024
Evaluating the Effect of Lockdowns On All-Cause Mortality During the COVID Era: Lockdowns Did Not Save LivesJuly 2022
Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID-19 mRNA Vaccination Among U.S. Children Aged 2-5 YearsMarch 19, 2024
Evidence for a connection between coronavirus disease-19 and exposure to radiofrequency radiation from wireless communications including 5GSeptember 29, 2021
Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patientsAugust 16, 2022
Evidence Regarding Vitamin D and Risk of COVID-19 and Its SeverityOctober 31, 2020
Excess and Exiguous Deaths Dashboard in Japan
Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, WashingtonMay 27, 2024
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countriesMay 19, 2021
Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 PandemicJanuary 2024
Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022June 3, 2024
Excess Mortality in Cyprus during the COVID-19 EpidemicFebruary 12, 2024
Excess mortality in Germany 2020-2022August 2022
Excess non-COVID-19 mortality in Norway 2020–2022January 22, 2024
Excess Weight and COVID-19: Insights from new evidenceJuly 2020
Expert testimony of Dr. Christina Parks, PhDAugust 25, 2021
Experts and talking heads claim covid vaccines stop transmission compilationOctober 17, 2021
Exploring inter-country coronavirus mortalityJuly 9, 2020
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approachMarch 25, 2021
Explosive: Embalmer reveals 93% of cases have deadly clots caused by the COVID vaxFebruary 12, 2022
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variantNovember 2, 2021
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in miceNovember 2, 2022
External peer review of the RTPCR test to detect SARS-CoV-2 reveals 10 major scientific flaws at the molecular and methodological level: consequences for false positive resultsNovember 30, 2020
Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trialOctober 13, 2020
Facemask versus No Facemask in Preventing Viral Respiratory Infections During Hajj: A Cluster Randomised Open Label TrialMarch 11, 2019
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers)Revised December 22, 2022
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) — Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19)Revised May 5, 2022
Fact Sheet for Recipients and Caregivers - Emergency Use Authorization (EUA) of the Pfizer-Biontech COVID-19 Vaccine to Prevent CoronavirusRevised August 12, 2021
FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT THE PFIZERBIONTECH COVID-19 VACCINE AND THE PFIZER-BIONTECH COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) FOR USE IN INDIVIDUALS 6 MONTHS THROUGH 4Revised December 8, 2022
FAQ about COVID-19September 17, 2021
Fauci on Antibody Dependent Enhancement (ADE)March 2020
FDA Briefing Document - Moderna COVID-19 VaccineDecember 17, 2020
FDA Briefing Document - Pfizer-BioNTech COVID-19 VaccineDecember 10, 2020
FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee MeetingDecember 10, 2020
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 VaccineDecember 11, 2020
FDA tweet on Ivermectin in August 2021August 21, 2021